ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,297,305 | -25.4% | 159,989 | -0.1% | 0.01% | -25.0% |
| Q2 2023 | $5,757,718 | +87.9% | 160,070 | +28.7% | 0.01% | +100.0% |
| Q1 2023 | $3,064,132 | -39.1% | 124,356 | -1.1% | 0.00% | -50.0% |
| Q4 2022 | $5,029,302 | +11.5% | 125,764 | -5.3% | 0.01% | +14.3% |
| Q3 2022 | $4,509,000 | +0.9% | 132,841 | -0.8% | 0.01% | 0.0% |
| Q2 2022 | $4,468,000 | -12.4% | 133,979 | +23.6% | 0.01% | +16.7% |
| Q1 2022 | $5,100,000 | -30.8% | 108,416 | +1.0% | 0.01% | -33.3% |
| Q4 2021 | $7,374,000 | +10.7% | 107,338 | -0.2% | 0.01% | 0.0% |
| Q3 2021 | $6,660,000 | +8.4% | 107,596 | +45.1% | 0.01% | +12.5% |
| Q2 2021 | $6,142,000 | +1128.4% | 74,155 | +892.2% | 0.01% | +700.0% |
| Q1 2021 | $500,000 | – | 7,474 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |